Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia

PURPOSE: The receptor for advanced glycation end products (RAGE) has been implicated in the pathogenesis of numerous complications of diabetes. We assessed the effect of a novel RAGE fusion protein inhibitor on retinal histopathology and nerve function, and on retinal inflammation and oxidative stre...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Guangyuan, Tang, Jie, Du, Yunpeng, Lee, Chieh Allen, Kern, Timothy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235538/
https://www.ncbi.nlm.nih.gov/pubmed/22171162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235538/
https://www.ncbi.nlm.nih.gov/pubmed/22171162

Ejemplares similares